STOCK TITAN

Vendome Acquisition I (VNME) SEC Filings, Nov 2025-Feb 2026

VNME NASDAQ
Rhea-AI Summary

Barclays PLC filed an amended Schedule 13G reporting its beneficial ownership in Vendome Acquisition Corp-A common stock. Barclays reports beneficial ownership of 450 shares, representing 0.00% of the class. Barclays has sole voting and dispositive power over these 450 shares and no shared power.

The filing confirms that the holdings are below 5% of the outstanding common stock and are held in the ordinary course of business, not for the purpose of changing or influencing control of Vendome Acquisition Corp-A.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.30%
Tags
ownership
-
Rhea-AI Summary

Vendome Acquisition Corporation I (VNME) filed its quarterly report as a newly formed SPAC after completing its July Initial Public Offering of 20,000,000 units at $10.00 each, raising $200,000,000 plus $2,648,000 from private placement warrants.

As of September 30, 2025, the company reported total assets of $202,785,616, including $202,068,698 of cash held in a trust account and $399,771 of cash outside the trust. Net income for the three months ended September 30, 2025 was $1,820,558, driven by $2,068,698 of interest income on trust investments and $248,140 of formation and operating expenses.

All 20,000,000 Class A ordinary shares are redeemable at approximately $10.10 per share, and 5,000,000 Class B founder shares remain outstanding. Vendome has 24 months from the IPO closing to complete a business combination, with working capital supported by funds outside the trust and potential sponsor-backed working capital loans and a convertible note of up to $840,000.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.40%
Tags
quarterly report

FAQ

How many Vendome Acquisition I (VNME) SEC filings are available on StockTitan?

StockTitan tracks 12 SEC filings for Vendome Acquisition I (VNME), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Vendome Acquisition I (VNME)?

The most recent SEC filing for Vendome Acquisition I (VNME) was filed on November 16, 2026.